Browsing Tag
Knight Therapeutics
1 post
Pharmaceutical shake-up: Mallinckrodt and Endo to merge in blockbuster $6.7bn deal
Mallinckrodt plc and Endo, Inc. have announced a definitive agreement to merge in a stock and cash transaction…